A Multicenter, Randomized, Double-Blind, Positive-Controlled, Cross-Over Phase ??? Clinical Trial Evaluating the Efficacy and Safety of HRS-9231 for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Latest Information Update: 16 Dec 2025
At a glance
- Drugs Gadobutrol (Primary) ; HRS 9231 (Primary)
- Indications CNS disorders
- Focus Diagnostic use; Registrational
- Sponsors Shanghai Shengdi Pharmaceutical
Most Recent Events
- 16 Dec 2025 New trial record